Telemetry Investments, L.L.C. Bellerophon Therapeutics, Inc. Transaction History

Telemetry Investments, L.L.C.

$63.3 Million
Q4 2022

A detailed history of Telemetry Investments, L.L.C. transactions in Bellerophon Therapeutics, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 44,000 shares of BLPH stock, worth $1,760. This represents 0.06% of its overall portfolio holdings.

Number of Shares

44,000

Previous 47,500 7.37%

Holding current value

$1,760

Previous $52,000 23.08%

% of portfolio

0.06%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.67 - $1.2 $2,345 - $4,200	-3,500 Reduced 7.37%	44,000 $40,000
Q3 2022 Nov 17, 2022	SELL	$0.96 - $1.69 $20,640 - $36,335	-21,500 Reduced 31.16%	47,500 $52,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $2.36 $12,396 - $34,418	-14,584 Reduced 17.45%	69,000 $85,000
Q1 2022 May 16, 2022	SELL	$1.82 - $3.24 $34,938 - $62,198	-19,197 Reduced 18.68%	83,584 $197,000
Q4 2021 Feb 14, 2022	BUY	$2.36 - $4.05 $40,783 - $69,988	17,281 Added 20.21%	102,781 $319,000
Q3 2021 Nov 15, 2021	SELL	$3.75 - $4.86 $20,325 - $26,341	-5,420 Reduced 5.96%	85,500 $347,000
Q2 2021 Aug 16, 2021	BUY	$3.83 - $5.65 $114,432 - $168,810	29,878 Added 48.95%	90,920 $440,000
Q1 2021 May 17, 2021	SELL	$5.07 - $8.27 $151,298 - $246,793	-29,842 Reduced 32.84%	61,042 $317,000
Q4 2020 Feb 16, 2021	SELL	$6.12 - $10.37 $160,711 - $272,316	-26,260 Reduced 22.42%	90,884 $606,000
Q3 2020 Nov 16, 2020	SELL	$9.27 - $13.79 $72,825 - $108,334	-7,856 Reduced 6.28%	117,144 $1.19 Million
Q2 2020 Aug 14, 2020	BUY	$9.43 - $20.28 $707,250 - $1.52 Million	75,000 Added 150.0%	125,000 $1.57 Million
Q1 2020 May 15, 2020	BUY	$3.39 - $18.0 $169,500 - $900,000	50,000 New	50,000 $548,000

Others Institutions Holding BLPH

# of Institutions

Shares Held

44K

Call Options Held

Put Options Held

View Full List

About Bellerophon Therapeutics, Inc.

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $382K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

More about BLPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.

Account

Telemetry Investments, L.L.C. Bellerophon Therapeutics, Inc. Transaction History